Biological Information
Background Information:
The receptor tyrosine kinase FLT-3 (fms-related tyrosine kinase 3, STK1) appears to play an important role in the development of hematopoietic stemcells, dendritic cells, B progenitor cells, and natural killer (NK) cells. On binding FLT3 ligand, the wild-type receptor dimerizes, activating its tyrosine kinase domain with resultant autophosphorylation. RAS-GAP, PLC-g, PI3-kinase, STAT5, and ERK1/2 are important signaling proteins linked to activation of FLT3. FLT3 is aberrantly expressed in the malignant cells in the majority of patients with acute myeloid leukemia (AML).
Family:
Kinase
Sub Family:
RTK
Class:
Protein Tyrosine
Protein Name:
FLT3
Uniprot Number:
P36888
Protein Aliases:
FL cytokine receptor|Fetal liver kinase-2|FLK-2|Fms-like tyrosine kinase 3|FLT-3|Stem cell tyrosine kinase 1|STK-1|CD antigen CD135
Gene Name:
FLT3
Gene ID:
2322
Gene Aliases:
STK1|FLK2|CD135
Accession Number:
NP_004110.2
Organism:
Human
Construct Details:
Wild Type; Partial Length (Start/Stop: H564/Y969); Mammalian Expression
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Binding
Testing Information
Test Sample Requirements:
50uL of a 1000X stock based on the top or final concentration being tested
Minimum Order Quantity:
24
Turnaround Time
Standard:
14 Business Days
Clinical Relevance
Adverse / Beneficial Action:
FLT3 inhibitors may lead to new approaches for the treatment of acute myeloid leukemia (AML) and other forms of cancer.
Additional Information
Brand:
LeadHunter
Testing Location:
USA - San Diego, CA